|Publication number||US7608099 B2|
|Application number||US 11/357,366|
|Publication date||Oct 27, 2009|
|Filing date||Feb 17, 2006|
|Priority date||Oct 26, 2002|
|Also published as||CA2503563A1, EP1553903A2, EP1553903A4, US8267987, US20040093056, US20060200222, US20100004732, WO2004039242A2, WO2004039242A3|
|Publication number||11357366, 357366, US 7608099 B2, US 7608099B2, US-B2-7608099, US7608099 B2, US7608099B2|
|Inventors||Liann M Johnson, Paul S Sherburne, Alicia F. Heck, Ricci D. Smelser, Eric K Mangiardi|
|Original Assignee||Merit Medical Systems Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (104), Non-Patent Citations (8), Referenced by (22), Classifications (13), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of U.S. application Ser. No. 10/281,429, filed Oct. 26, 2002, now abandoned which is hereby incorporated herein in its entirety by reference.
The present invention relates generally to medical devices directed to the prevention of nonvascular vessel or passageway occlusion, and more particularly to stent deployment apparatuses and methods for utilizing these devices in the treatment of both benign and malignant conditions.
Stents are devices that are inserted into a vessel or passage to keep the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, stents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Nonvascular stenting involves a range of anatomical lumens and various therapeutic approaches, however, accuracy of installation is universally important.
In order to serve its desired function, the stent must be delivered precisely and oriented correctly. In order to facilitate the delivery of stents, medical device companies began to design deployment apparatuses that allow physicians to deploy stents more precisely. Unfortunately, guidance of the stent has substantially remained a function of physician skill resulting from substantial practice. This fact has become particularly evident with the advent of radially expanding stents. If after full deployment of the stent, the physician discovers the stent has been implanted incorrectly, there is no conventional way of correcting the error short of removing the stent. In particular, as a rule of thumb, once the exterior catheter, of conventional delivery devices, has been retracted beyond 60%, it generally cannot be realigned with respect to the stent. As a result, physicians must be sure of their stent placement prior to deploying the stent beyond the 60% point. We will refer to this 60% point throughout the application as the critical deployment point.
Conventional stent delivery devices, however, do not have any safety mechanism to prevent excessive deployment of a misaligned stent. In fact, conventional delivery devices require the physician to estimate extent of deployment, which results in either overly conservative or excessive deployment—both of which leads to stent misplacement.
An additional limitation of conventional stent delivery devices is the distal tip of conventional stent delivery devices are not adequately designed to (1) facilitate the clearance of obstructed lumen, or (2) facilitate the removal of the delivery device once the stent is radially expanded. In particular, most distal tips are not configured to comfortably guide the delivery device through a diseased or occluded lumen so that the stent can be delivered in the most beneficial location. Moreover, once the stent is radially expanded conventional designs rely exclusively on dimensional mismatching to ensure proper removal of the delivery device. In the event the stent does not adequately expand to preset dimensions, a conventional delivery device would be stuck in the patient until some invasive procedure is performed to remove it and the defective stent.
Therefore, there remains an existing need for a stent deployment apparatuses that has a safety mechanism to prevent excessive deployment of a misaligned stent. Preferably it would be desirable if the safety mechanism had a physical and/or audible indication means to inform the physician when she has reached maximum reversible deployment. As an additional safety feature, there is an existing need for a distal tip designed to allow for the removal of the deployment apparatus even if the stent does not radially expand to its preset expansion diameter. An existing need also exists for a stent deployment apparatus that has a distal tip adequately configured to navigate through diseased and/or occluded lumens so that the stent can be delivered to this target area.
There also remains an existing need for a stent deployment apparatus that increases physician control during stent deployment. Moreover, there exists a need for a stent deployment apparatus that allows for the insertion of an optical scope to facilitate stent delivery.
It is a principal objective of an exemplary stent deployment apparatus in accordance with the present invention to provide a device that can facilitate the precise delivery of stents in a safe and repeatable fashion. In the furtherance of this and other objectives, a preferred deployment apparatus allows the physician to concentrate on correct placement without having to estimate extent of deployment. In particular, in a preferred embodiment, the present deployment apparatus has a physical safety mechanism that limits deployment to the critical deployment point (i.e., ˜60%). The critical deployment point may range form 5% to 95% but is preferably about 60%. At this point, if the physician is satisfied with placement, she can engage the safety means to what we refer to as the Proceed Orientation (PO) and fully deploy the stent. It is preferred that when the safety mechanism is engaged to the PO, a physical twist and a possible audible indicator sounds to inform the physician that if she deploys the stent any further, she can no longer retract the stent beyond this point. Though the present stent and delivery system eliminates the need for repositioning, such safety features are still preferable. In a preferred embodiment, the slight audible indication is the sound of a tab or stop snapping to allow free deployment of the stent.
An additional objective of a preferred embodiment of the present invention is to provide a stent deployment apparatus where the handle portion is held and the outer tubular member of the device is retracted.
Yet another objective in accordance with the present invention is to provide a deployment apparatus having a distal tip designed to facilitate the clearance of obstructed lumen. In the furtherance of this and other objectives, the exemplary distal tips are configured to comfortably guide the deployment apparatus through a diseased or occluded lumen so that the stent can be delivered in the most beneficial location.
Still another objective of a preferred deployment apparatus in accordance with the present invention is to provide a distal tip that facilitates the removal of the deployment apparatus once the stent is radially expanded. In the furtherance of this and other objectives, the distal tip is designed to clear the stent during removal, in the event the stent does not adequately expand to preset dimensions. In a preferred embodiment, removal is facilitated by providing a distal tip that has a substantially bidirectional conic shape. This allows for the removal of the present deployment apparatus, while conventional deployment apparatuses would be stuck in the patient until some invasive procedure was performed to remove it and the defective stent. This results from the fact that conventional deployment apparatus designs rely exclusively on dimensional mismatching between the distal tip and the radially expanded stent to ensure proper removal of the deployment apparatus. As a function of the design of the present invention, the compressed stent is adequately retained in place and does not prematurely creep up the proximally facing conic end of the distal tip and prematurely deploy.
An additional objective in accordance with an exemplary embodiment of the present invention is to provide a stent deployment apparatus that allows for the insertion of an optical scope to facilitate stent delivery. In the furtherance of this and other objectives, the device is capable of letting a flexible optical scope of about 5-6 mm diameter be coupled along the exterior of the outer tubular member thereof. Alternatively, it is envisioned that an ultra thin optical scope may pass along side the guidewire through the internal diameter of the internal tubular member of the device.
In addition to the above objectives, an exemplary stent deployment apparatus preferably has one or more of the following characteristics: (1) applicable for various interventional applications such as addressing stenosis; (2) biocompatible; (3) compliant with radially expanding stents; (4) capable of distal or proximal stent release; (5) smooth and clean outer surface; (6) length of the device variable according to the insertion procedure to be employed; (7) outer dimension as small as possible (depends on the diameter of crimped stent); (8) dimensions of the device must offer enough space for the crimped stent; (9) radiopaque markers, preferably on the inner tubular member, to indicate proximal and distal ends of the stent; (10) sufficient flexibility to adapt to luminal curvatures without loss of ability to push or pull; (11) low friction between the inner tubular member and outer tubular member; (12) sufficient resistance to kinking; (13) good deployment, ability to reposition partially deployed stent; (14) added with a scale to observe the stent position during the insertion procedure; (15) insertion procedure should require low force; or (16) sufficiently economical to manufacture so as to make the deployment apparatus disposable.
Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.
A general problem in the diagnosis and therapy of both vascular and nonvascular anomalies is the fact that the instruments must be inserted into or pass the area of maximum diameter of about 15 mm. As a result, the inserted instruments take away a very large portion of the free lumen and may increase the danger of injury to the patient.
Therefore, it is the primary objective of the present invention to provide an instrument, which con be inserted gently, ensures a good utilization of the available space and makes it possible to carry out active therapeutic measures, wherein the instrument is to be particularly suitable for the introduction and placement of stents.
A preferred embodiment of the present deployment apparatus comprises inner and outer tubular members interactively coupled with each other in a manner that one can move rotationally and proximally or distally with respect to the other. The tubular members are preferably nonpyrogenic. In order to deliver the stent, the deployment apparatus comprises a distal tip and a stent retaining hub, between which the stent is placed. The distal tip and the stent-retaining hub are both functionally coupled with the inner tubular member. The inner tubular member terminates with a luer or in a preferred embodiment, a proximal handle similar to the outer handle hub. The luer is preferably a female threaded luer, but alternative termini are within the skill of the stent deployment device engineer. In fact, a suitable alternative would be a handle having similar internal diameter characteristics as the luer while providing greater surface area for manipulating the deployment apparatus. As stated above, a preferred alternative would be a proximal handle that is similar in geometrical shape but preferably smaller than the outer handle hub, to facilitate movement, however the proximal handle may be of any size functionally acceptable by the user. The deployment apparatus is preferably sterilized by a validated sterilization cycle EtO. Moreover, the device is capable of resterilization (validated cycle) with no degradation of performance. However, it is preferable to provide a disposable device.
The deployment apparatus is preferably about 100 cm±2 cm total. The inner diameter of the inner tubular member is approximately about 1 mm and the outer diameter of the outer tubular member is preferably about 5 to 6 mm in diameter. For purposes of this discussion, the usable length of the inner tubular member shall be from the inner tubular member distal hub/handle end to the distal tip. The usable length of the outer tubular member shall be from the distal hub/handle end of the outer tubular member to the distal tip. The overall length of the device shall be from the distal hub/handle end of the outer tubular member to the distal tip of the inner tubular member when assembled and not deployed. There will also be preferably three radiopaque (platinum iridium) markers for marking the stent, the stent deployment distance, and depth. The outer tubular member is preferably manufactured of stiffer synthetic material. In a preferred embodiment, the length of the outer tubular member is preferably shorter than that of the inner tubular member.
However, these dimensions may differ as a function of the stent diameter and/or if an optical scope is employed to facilitate stent delivery. The outer tubular member may be configured to allow for the coupling of an optical scope along the outer diameter thereof. Alternatively, the inner diameter of the inner tubular member may be enlarged sufficiently to accommodate the optical scope and additionally the increased crimped stent diameter. However, it is expected, though not required, that the smallest diameter that allows for example a bronchoscope to pass will be employed in this alternative embodiment. It should be understood that through hindsight, after exposure to the present specification, one of ordinary skill would be able to adapt the current device to receive an ultra thin optical scope to the internal diameter of the device without undo experimentation and without departing from the spirit of the present objectives.
An exemplary deployment apparatus in accordance with the present invention is durable while affording adequate flexibility to navigate through anatomical lumens without kinking. To this end, it is preferable that the deployment apparatus is formed of biocompatible synthetics and in a preferred embodiment reinforced with metal structure. This should allow for deployment within an accuracy of about ±3 mm. Moreover, the stent is preferably released with a force lower than 30 Newtons at 37° C. though the force and deployment temperatures may be modified to suit the needs of specific anatomical conditions.
The inner tubular member is composed of a thin elastic synthetic material, such as polyurethane or Teflon®. At its proximal end, the inner tubular member has a standard adaptor or connector. At its distal end, the inner tubular member is equipped with a tip specific for various anatomical lumens.
The inner tubular member and the outer tubular member can be displaced relative to each other in longitudinal direction as well as in a radial direction. The deployment apparatus in accordance with the present invention can be used most advantageously for the placement of stents. Such stents are available in various embodiments of metal and/or synthetic material. They usually are composed of a fabric of metal wires, which expand by themselves as a result of their natural tension. Stents of a so-called shape memory alloy are also known. These stents have a small radial diameter at a low temperature, while they expand radially when exceeding an upper threshold temperature, so that they can keep a stenosis open in this manner. It is particularly advantageous to use stents of an alloy of nickel and titanium, the so-called nitinol.
An exemplary deployment apparatus according to the present invention can be used for the placement of various stents, whether they are self-expanding stents or stents, which require an activation. For this purpose, the stent is placed in the free space between the outer tubular member and the inner tubular member. Positioning of the stent in the deployment apparatus can be carried out in the area between the tip and the stent retaining hub at the distal end of the inner tubular member. Alternatively, in its insertion position, fasteners or other suitable retaining elements may hold the stent.
In relevant embodiments, when the stent is inserted and after the stenosis has been passed, the outer tubular member is retracted, so that the stent is released. Alternatively, the distal end of the outer tubular member may be placed about the stenosis so that the inner tubular member may be extended so that the stent is placed in direct contact with the desired location prior to expansion. A self-expanding stent then by itself assumes the expanded position. This eliminates the need for post expansion positioning techniques. With an alternative embodiment of the device, the device has fasteners that retain contact with a portion of the stent in the event that the stent needs to be retracted or repositioned. A stent suitable for such procedures would be one in accordance with the disclosure in co-pending U.S. patent application Ser. No. 10/190,770, which is incorporated herein in its entirety by this reference.
The following reference numbers and corresponding stent placement and deployment device components are used when describing the device in relation to the figures:
Stent Delivery & Deployment Device
Proximal Handle/Female Threaded Luer
Female Locking Member on the Stop
Tab of the Stop
Inner Tubular Member
Inner Diameter of Inner Tube
Cavity in Proximal Portion of Handle
Base of Handle Cavity
Male Locking Member
Inner Handle Hub
Outer Handle Hub
Outer Tubular Member
Outer Diameter of Outer Tubular Member
Distal Region of Outer Tubular Member
Inner Diameter of Outer Tubular Member
First End of the Tip
Medial Region of the Tip
Second End of the Tip
Distal Region of Retaining Hub
Proximal Hub of Retaining Hub
The figures show an exemplary placement and deployment device 10 in accordance with the present invention. Referring in particular to
As illustrated in
The handle 40 is preferably molded to a portion of the outer tubular member 50, which extends from the handle 40 to the distal tip 60 of the device 10. The outer tubular member 50 is disposed about the inner tubular member 30. In an exemplary embodiment, the outer tubular member 50 is clear so that the inner tubular member 50 is visible there through. Moreover, markers 80-84 preferably formed on portions of the inner tubular member 30 are also visible through the outer tubular member 50.
Referring now to
The device is configured such that an optional guidewire 12 may be passed through the internal diameter 32 of the device through the luer 14 at the proximal end, the distal tip 60 at the distal end and the inner tubular member 30 there between. In an alternative embodiment, the internal diameter 32 of the device 10 is sufficient to receive an optical scope (not shown) there through.
Referring to the functional aspects of the device 10, there is shown in
Outer tubular member 50 is mounted at its proximal end to a handle 40. Outer tubular member 50 can be pushed and pulled relative to inner tubular 30 by hand manipulation of the handle 40 at the proximal end of the outer tubular member 50 and holding the proximal end of the handle 14.
A guidewire 12 is preferably disposed within the interior lumen 32 of an elongate and flexible inner tubular member 30, which can be constructed of materials similar to those employed to form the outer tubular member 50. However, it is preferable that inner tubular member 30 is formed from a more durable material. A distal tip 60 is coupled with inner tubular member 30 about the distal end thereof. Also attached to the inner tubular member 30 are a proximal marker 80, at least one medial marker 82 and a distal marker 84. The markers are constructed of a radiopaque material, e.g. platinum iridium, and surround the inner tubular member 30. Markers 80, 82 and 84 are axially spaced apart to mark the length of the stent and to mark the critical deployment distance for that stent length. The markers identify a stent-retaining hub 70 of the inner tubular member 30, more particularly the distal region of the inner tubular member 30 is surrounded by stent 12. The markers may also be of varying sizes and shapes to distinguish distance between distal and proximal regions. Markers 80 and 84 may have outer diameters slightly smaller than the interior diameter of outer tubular member 50. The outer tubular member 50 thus functions as a carrier for the stent, with inner tubular member 30 providing a retaining means for radially compressing the stent and maintaining the stent along the stent retaining hub 50, so long as the outer tubular member 50 surrounds the stent.
In an alternative embodiment, items 72 and 74 are marker bands (not retaining hubs) formed on the outer tubular member 50. These marker bands visually mark the ends of the stent and thus will be over the step area of the tip and the pusher 76. All the marker bands—including 80, 82 and 84 are preferably either Platinum Iridium or Stainless Steel. Moreover, the marker bands of 80, 82, and 84 will be depth marks and will be spaced in preferably 1 cm intervals. These depth marks are preferably formed on the inner tubular member 30 and are a visual aid for the physician to assist with determining the depth at which the stent has been advanced.
Inner tubular member 30, along its entire length, has an interior lumen 56 open to both the proximal and distal ends of the inner tubular member 30. An axial passage 68 through distal tip 60 continues lumen 32 to allow the guidewire 12 to pass from the luer 14 through the distal tip 60.
Handle 40 and outer tubular member 50 are movable relative to inner tubular member 30. More particularly, the handle 40 is moved proximally relative to the stent-retaining hub 70, facilitating the movement of outer tubular member 50 relative to inner tubular member 30 so as to provide a means for controllably withdrawing the outer tubular member 50, relative to the inner tubular member 30, resulting in the release of the stent for radial self-expansion.
When the device 10 is used to position the stent, the initial step is to position guidewire 12 within the anatomy of a patient. This can be accomplished with a guide cannula (not illustrated), leaving guidewire 12 in place, with the exchange portion of the guidewire extended proximally beyond the point of entry into the anatomy of the patient. Deployment apparatus 10 is then advanced over the guidewire 12 at the exchange portion, with the guidewire 12 being received into passage 68 of distal tip 60. As device 10 is inserted into the body, the proximal portion of guidewire 12 travels proximally (relative to the device) to the proximal end of guidewire lumen 32.
Once device 10 is positioned, the physician maintains a guidewire 12 and inner tubular member 30 substantially fixed with one hand, while moving handle 40 in the proximal direction with the other hand, thus to move outer tubular member 50 proximally relative to inner tubular member 30. As the outer tubular member 50 is retracted, the stent remains substantially fixed relative to inner tubular member 30, and thus radially self-expands. As the handle 40 and correspondingly the outer tubular member 50 is retracted, the handle 40 encounters the safety mechanism 18 for the critical deployment point. The inner tubular member 30, via the handle 14, may have to be rotated to align and insert the stop 20 into the handle 40. When fully inserted, further deployment cannot occur without twisting and snapping the tab 24 portion of the stop 20. Continued retraction of the outer tubular member 50 results in complete deployment of the stent.
After deployment, the stent ideally radially self-expands to a diameter greater than the diameter of outer tubular member 50. Accordingly, device 10 can be withdrawn proximally through the stent. However, in the event that the stent does not radially expand fully, distal tip 60 is configured to facilitate removal of deployment apparatus 10 through the lumen of the stent.
Guidewire 12 can be withdrawn as well. The guidewire 12 emerges from the proximal end of the luer 14. However, should the medical procedure involve further treatment, e.g., placement of a further stent, the deployment apparatus 10 can be removed without removing the guidewire 12. Device 10 is removed by progressively pulling the device away from the guidewire 12 (which removes the guidewire from within the inner tubular member 30), all while maintaining guidewire 12 in place.
Returning to distal tip 60, as illustrated in
With respect to additional safety features incorporated in the present device 10, in a preferred embodiment, the device 10 has a deployment safety mechanism 18 that comprises male 46 and female 22 locking members that are brought into functional engagement as the stent is being deployed. Once the stent has reached the critical deployment point, the distal end of the stop 20 is substantially flush with the base 44 of the handle cavity 42 and the female locking members 22 of the stop 20 are in operative communication with the corresponding male locking members 46 formed on the interior surface of the cavity 42 of the handle. When the safety mechanism 18 is engaged as described above, the stent cannot be deployed further without physician intervention. In order to deploy the stent beyond this point, the physician has to rotate the stop 20 to cause the tab 24 to break. Once the tab 24 is broken, the device 10 is in the proceed orientation and deployment may proceed.
In a preferred embodiment, the physician will feel a tactile indication that the device 10 can be deployed further. Alternatively, the breaking of the tab may also, or as a substitute to tactile indication, results in an audible indication that further deployment is possible. Additionally, the physician is apprised of the fact that deployment beyond this point is irreversible except for interventional retrieval methods. As discussed earlier, the critical deployment point is preferably about 60% deployment, beyond which retraction is not recommended. As a result, the safety mechanism 18 removes the need to estimate extent of deployment and provides a reliable means of accurately deploying stents. Alternative locking mechanisms may be provided as long as they retain the important characteristic of giving the physician a sensory indication of extent of stent deployment and removes the need to estimate extent of deployment. By way of non-limiting example only, the locking mechanism could comprise a breakable seal, tab/stop lock, diverted channel locking mechanism, etc.
Referring particularly to
In an additional embodiment (not shown) of deployment safety mechanism 118, the device 10 has a deployment safety mechanism that comprises male and female locking members that are brought into functional engagement as the stent 12 is being deployed. Once the stent 12 has reached the critical deployment point, the male locking member cannot be advanced further because of a detent formed on the inner diameter of the outer tubular member catches the cavity formed on the corresponding portion of the male locking member. As a result, in order to further advance the device 10 to fully deploy stent 12, the inner tubular member must be rotated so as to break the detent. Once the detent is broken, the physician will feel a tactile indication that the device 10 can be deployed further.
Alternatively, the breaking of the detent may also, or as a substitute to tactile indication, results in an audible indication that further deployment is possible. Additionally, the physician is apprised of the fact that deployment beyond this point is irreversible except for interventional retrieval methods. As discussed earlier, the critical deployment point is preferably about 60% deployment, beyond which retraction is not recommended. As a result, the safety locking system 60 removes the need to estimate extent of deployment and provides a reliable means of accurately deploying stents. Alternative locking mechanisms may be provided as long as they retain the important characteristic of giving the physician a sensory indication of extent of stent deployment.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3196876||May 10, 1961||Jul 27, 1965||Miller Maurice M||Dilator|
|US4343048||Aug 4, 1980||Aug 10, 1982||Ross Donald N||Stent for a cardiac valve|
|US4606330||Jul 19, 1984||Aug 19, 1986||Richard Wolf Gmbh||Device for disintegrating stones in bodily cavities or ducts|
|US4665906||May 21, 1986||May 19, 1987||Raychem Corporation||Medical devices incorporating sim alloy elements|
|US4680031||Oct 24, 1984||Jul 14, 1987||Tascon Medical Technology Corporation||Heart valve prosthesis|
|US4733665||Nov 7, 1985||Mar 29, 1988||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US4739762||Nov 3, 1986||Apr 26, 1988||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US4820262||Dec 12, 1985||Apr 11, 1989||Medical Engineering Corporation||Ureteral stent|
|US4893623||Nov 20, 1987||Jan 16, 1990||Advanced Surgical Intervention, Inc.||Method and apparatus for treating hypertrophy of the prostate gland|
|US5019085||Feb 23, 1990||May 28, 1991||Cordis Corporation||Apparatus and method for placement of a stent within a subject vessel|
|US5032128||Jul 7, 1988||Jul 16, 1991||Medtronic, Inc.||Heart valve prosthesis|
|US5067957||Sep 27, 1988||Nov 26, 1991||Raychem Corporation||Method of inserting medical devices incorporating SIM alloy elements|
|US5073694||Feb 21, 1991||Dec 17, 1991||Synthes (U.S.A.)||Method and apparatus for laser cutting a hollow metal workpiece|
|US5102417||Mar 28, 1988||Apr 7, 1992||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US5104404||Jun 20, 1991||Apr 14, 1992||Medtronic, Inc.||Articulated stent|
|US5159920 *||Jun 18, 1990||Nov 3, 1992||Mentor Corporation||Scope and stent system|
|US5190546||Apr 9, 1991||Mar 2, 1993||Raychem Corporation||Medical devices incorporating SIM alloy elements|
|US5195984||Feb 19, 1991||Mar 23, 1993||Expandable Grafts Partnership||Expandable intraluminal graft|
|US5249585||Nov 5, 1990||Oct 5, 1993||Bsd Medical Corporation||Urethral inserted applicator for prostate hyperthermia|
|US5292331||Aug 24, 1989||Mar 8, 1994||Applied Vascular Engineering, Inc.||Endovascular support device|
|US5320617||Jun 25, 1993||Jun 14, 1994||Leach Gary E||Method of laser-assisted prostatectomy and apparatus for carrying out the method|
|US5345057||Mar 25, 1993||Sep 6, 1994||Lasag Ag||Method of cutting an aperture in a device by means of a laser beam|
|US5354309||Oct 13, 1992||Oct 11, 1994||Angiomed Ag||Apparatus for widening a stenosis in a body cavity|
|US5356423||Apr 22, 1993||Oct 18, 1994||American Medical Systems, Inc.||Resectable self-expanding stent|
|US5383892||Nov 6, 1992||Jan 24, 1995||Meadox France||Stent for transluminal implantation|
|US5409453||Aug 19, 1993||Apr 25, 1995||Vidamed, Inc.||Steerable medical probe with stylets|
|US5421955||Mar 17, 1994||Jun 6, 1995||Advanced Cardiovascular Systems, Inc.||Expandable stents and method for making same|
|US5433723 *||Feb 28, 1994||Jul 18, 1995||Angiomed Ag||Apparatus for widening a stenosis|
|US5443498||Dec 6, 1993||Aug 22, 1995||Cook Incorporated||Vascular stent and method of making and implanting a vacsular stent|
|US5449373||Mar 17, 1994||Sep 12, 1995||Medinol Ltd.||Articulated stent|
|US5514093||May 19, 1994||May 7, 1996||Scimed Life Systems, Inc.||Variable length balloon dilatation catheter|
|US5514154||Jul 28, 1994||May 7, 1996||Advanced Cardiovascular Systems, Inc.||Expandable stents|
|US5534287||Nov 29, 1994||Jul 9, 1996||Schneider (Europe) A.G.||Methods for applying an elastic coating layer on stents|
|US5549644||Feb 2, 1994||Aug 27, 1996||Vidamed, Inc.||Transurethral needle ablation device with cystoscope and method for treatment of the prostate|
|US5588949||Apr 13, 1994||Dec 31, 1996||Heartport, Inc.||Stereoscopic percutaneous visualization system|
|US5591157||Sep 7, 1994||Jan 7, 1997||Hennings; David R.||Method and apparatus for tympanic membrane shrinkage|
|US5591197||Mar 14, 1995||Jan 7, 1997||Advanced Cardiovascular Systems, Inc.||Expandable stent forming projecting barbs and method for deploying|
|US5593442||Jun 5, 1995||Jan 14, 1997||Localmed, Inc.||Radially expansible and articulated vessel scaffold|
|US5597378||Oct 2, 1992||Jan 28, 1997||Raychem Corporation||Medical devices incorporating SIM alloy elements|
|US5601591||Sep 23, 1994||Feb 11, 1997||Vidamed, Inc.||Stent for use in prostatic urethra, apparatus and placement device for same and method|
|US5601593||Aug 18, 1995||Feb 11, 1997||Willy Rusch Ag||Stent for placement in a body tube|
|US5603698||Aug 23, 1995||Feb 18, 1997||Boston Scientific Corporation||Prosthesis delivery system|
|US5609629||Jun 7, 1995||Mar 11, 1997||Med Institute, Inc.||Coated implantable medical device|
|US5618300||Aug 10, 1995||Apr 8, 1997||Endovascular Systems, Inc.||Apparatus and method for deployment of radially expandable stents by a mechanical linkage|
|US5628788||Nov 7, 1995||May 13, 1997||Corvita Corporation||Self-expanding endoluminal stent-graft|
|US5643312||Feb 25, 1994||Jul 1, 1997||Fischell Robert||Stent having a multiplicity of closed circular structures|
|US5662713||Sep 14, 1995||Sep 2, 1997||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5667522||Mar 2, 1995||Sep 16, 1997||Medinol Ltd.||Urological stent and deployment device therefor|
|US5681346||Jan 6, 1997||Oct 28, 1997||Advanced Cardiovascular Systems, Inc.||Expandable stent forming projecting barbs and method for deploying|
|US5690644||Feb 20, 1996||Nov 25, 1997||Schneider (Usa) Inc.||Apparatus for deploying body implantable stent|
|US5695499||Oct 21, 1996||Dec 9, 1997||Schneider (Usa) Inc.||Medical device supported by spirally wound wire|
|US5702418||Sep 12, 1995||Dec 30, 1997||Boston Scientific Corporation||Stent delivery system|
|US5707386||Jan 22, 1994||Jan 13, 1998||Angiomed Gmbh & Company Medizintechnik Kg||Stent and method of making a stent|
|US5713949||Aug 6, 1996||Feb 3, 1998||Jayaraman; Swaminathan||Microporous covered stents and method of coating|
|US5716393||May 20, 1995||Feb 10, 1998||Angiomed Gmbh & Co. Medizintechnik Kg||Stent with an end of greater diameter than its main body|
|US5733303||May 31, 1995||Mar 31, 1998||Medinol Ltd.||Flexible expandable stent|
|US5741333||Apr 3, 1996||Apr 21, 1998||Corvita Corporation||Self-expanding stent for a medical device to be introduced into a cavity of a body|
|US5746692||Apr 8, 1996||May 5, 1998||Imagen Medical, Inc.||Catheter and endoscope system with distal protruding ball tip and method|
|US5755776||Oct 4, 1996||May 26, 1998||Al-Saadon; Khalid||Permanent expandable intraluminal tubular stent|
|US5759192||Jan 15, 1997||Jun 2, 1998||Advanced Cardiovascular Systems, Inc.||Method and apparatus for direct laser cutting of metal stents|
|US5766238||Mar 24, 1997||Jun 16, 1998||Advanced Cardiovascular Systems, Inc.||Expandable stents and method for making same|
|US5776140||Jul 16, 1996||Jul 7, 1998||Cordis Corporation||Stent delivery system|
|US5776161||Oct 16, 1995||Jul 7, 1998||Instent, Inc.||Medical stents, apparatus and method for making same|
|US5780807||Jan 15, 1997||Jul 14, 1998||Advanced Cardiovascular Systems, Inc.||Method and apparatus for direct laser cutting of metal stents|
|US5782838||Apr 21, 1997||Jul 21, 1998||Medtronic Instent, Inc.||Cytoscope delivery system|
|US5803080||Dec 20, 1996||Sep 8, 1998||Willy Rusch Ag||Instrument for interventional flexible tracheoscopy/bronchoscopy|
|US5807404||Sep 19, 1996||Sep 15, 1998||Medinol Ltd.||Stent with variable features to optimize support and method of making such stent|
|US5814063||Nov 27, 1996||Sep 29, 1998||Willy Rusch Ag||Stent for placement in a body tube|
|US5817102||Apr 21, 1997||Oct 6, 1998||Schneider (Usa) Inc.||Apparatus for delivering and deploying a stent|
|US5824042||Apr 5, 1996||Oct 20, 1998||Medtronic, Inc.||Endoluminal prostheses having position indicating markers|
|US5824058||Jul 21, 1997||Oct 20, 1998||Boston Scientific Corporation||Prosthesis delivery|
|US5830179||Apr 9, 1996||Nov 3, 1998||Endocare, Inc.||Urological stent therapy system and method|
|US5833694||May 16, 1997||Nov 10, 1998||Medtronic, Inc.||Stent assembly and method of use|
|US5836966||May 22, 1997||Nov 17, 1998||Scimed Life Systems, Inc.||Variable expansion force stent|
|US5837313||Jun 13, 1996||Nov 17, 1998||Schneider (Usa) Inc||Drug release stent coating process|
|US5843120||Jun 24, 1997||Dec 1, 1998||Medinol Ltd.||Flexible-expandable stent|
|US5860999||Nov 25, 1997||Jan 19, 1999||Angiomed Gmbh & Co.Medizintechnik Kg||Stent and method of using same|
|US5873904||Feb 24, 1997||Feb 23, 1999||Cook Incorporated||Silver implantable medical device|
|US5876445||Nov 26, 1996||Mar 2, 1999||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5876448||Mar 13, 1996||Mar 2, 1999||Schneider (Usa) Inc.||Esophageal stent|
|US5876449||Mar 29, 1996||Mar 2, 1999||Variomed Ag||Stent for the transluminal implantation in hollow organs|
|US5879370||May 28, 1997||Mar 9, 1999||Fischell; Robert E.||Stent having a multiplicity of undulating longitudinals|
|US5902333||Aug 21, 1995||May 11, 1999||Boston Scientific Corporation||Prosthesis delivery system with dilating tip|
|US5902475||Apr 8, 1997||May 11, 1999||Interventional Technologies, Inc.||Method for manufacturing a stent|
|US5911732||Mar 10, 1997||Jun 15, 1999||Johnson & Johnson Interventional Systems, Co.||Articulated expandable intraluminal stent|
|US5922020||Aug 2, 1996||Jul 13, 1999||Localmed, Inc.||Tubular prosthesis having improved expansion and imaging characteristics|
|US5922393||Jul 6, 1998||Jul 13, 1999||Jayaraman; Swaminathan||Microporous covered stents and method of coating|
|US5935162||Mar 16, 1998||Aug 10, 1999||Medtronic, Inc.||Wire-tubular hybrid stent|
|US5954729||Oct 24, 1997||Sep 21, 1999||Schneider (Usa) Inc.||Transluminal implantation device|
|US5968052 *||Nov 27, 1996||Oct 19, 1999||Scimed Life Systems Inc.||Pull back stent delivery system with pistol grip retraction handle|
|US5968070||Aug 11, 1997||Oct 19, 1999||Cordis Corporation||Covered expanding mesh stent|
|US5968091||Nov 26, 1997||Oct 19, 1999||Corvita Corp.||Stents and stent grafts having enhanced hoop strength and methods of making the same|
|US5972018||Feb 19, 1998||Oct 26, 1999||Medinol Ltd.||Flexible expandable stent|
|US5980552||Dec 4, 1996||Nov 9, 1999||Medinol Ltd.||Articulated stent|
|US5984964||Oct 31, 1996||Nov 16, 1999||Boston Scientific Corporation||Prothesis delivery system|
|US6017365||May 20, 1998||Jan 25, 2000||Jomed Implantate Gmbh||Coronary stent|
|US6019778||Mar 13, 1998||Feb 1, 2000||Cordis Corporation||Delivery apparatus for a self-expanding stent|
|US6022371||Jul 21, 1998||Feb 8, 2000||Scimed Life Systems, Inc.||Locking stent|
|US6033435||Nov 3, 1997||Mar 7, 2000||Divysio Solutions Ulc||Bifurcated stent and method for the manufacture and delivery of same|
|US6042597||Oct 23, 1998||Mar 28, 2000||Scimed Life Systems, Inc.||Helical stent design|
|US6048361||May 14, 1998||Apr 11, 2000||Jomed Implantate Gmbh||Balloon catheter and multi-guidewire stent for implanting in the region of branched vessels|
|US6051021||May 26, 1998||Apr 18, 2000||Medicorp, S.A.||Self-expanding endoprosthesis|
|US6203550 *||Jan 6, 1999||Mar 20, 2001||Medtronic, Inc.||Disposable delivery device for endoluminal prostheses|
|US6428538 *||Apr 11, 2000||Aug 6, 2002||United States Surgical Corporation||Apparatus and method for thermal treatment of body tissue|
|1||Final Office Action from related U.S. Appl. No. 10/404,197, mailed May 4, 2007.|
|2||Final Office Action from related U.S. Appl. No. 10/404,197, mailed May 5, 2008.|
|3||Office Action from corresponding Japanese Patent Application No. 2004-548493, completed Jul. 18, 2008.|
|4||Office Action from corresponding Japanese Patent Application No. 2004-548493, completed May 12, 2009.|
|5||Office Action from related U.S. Appl. No. 10/404,197, mailed Jul. 24, 2006.|
|6||Office Action from related U.S. Appl. No. 10/404,197, mailed Nov. 9, 2007.|
|7||PCT Notification of Transmittal of the International Search Report, PCT International Search Report mailed Jun. 24, 2004 for PCT/US03/33967 (Filed Oct. 25, 2003).|
|8||Related U.S. Appl. No. 10/404,197, filed Mar. 31, 2003, entitled "Medical Appliance Optical Delivery and Deployment Apparatus and Method."|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8038704||Jul 27, 2005||Oct 18, 2011||Paul S. Sherburne||Stent and other objects removal from a body|
|US8414635||May 22, 2008||Apr 9, 2013||Idev Technologies, Inc.||Plain woven stents|
|US8419788||Jul 13, 2012||Apr 16, 2013||Idev Technologies, Inc.||Secured strand end devices|
|US8470016||Sep 22, 2011||Jun 25, 2013||Paul Sherburne||Stent and other object removal from a body|
|US8597226||Jun 12, 2012||Dec 3, 2013||Jenavalve Technology, Inc.||Methods and conduits for flowing blood from a heart chamber to a blood vessel|
|US8739382||Jul 13, 2012||Jun 3, 2014||Idev Technologies, Inc.||Secured strand end devices|
|US8876880||Jul 13, 2012||Nov 4, 2014||Board Of Regents, The University Of Texas System||Plain woven stents|
|US8876881||Oct 22, 2007||Nov 4, 2014||Idev Technologies, Inc.||Devices for stent advancement|
|US8966733||May 28, 2014||Mar 3, 2015||Idev Technologies, Inc.||Secured strand end devices|
|US8974516||Dec 17, 2013||Mar 10, 2015||Board Of Regents, The University Of Texas System||Plain woven stents|
|US9023095||May 27, 2011||May 5, 2015||Idev Technologies, Inc.||Stent delivery system with pusher assembly|
|US9138315 *||Jun 14, 2007||Sep 22, 2015||Jenavalve Technology Gmbh||Medical device for treating a heart valve insufficiency or stenosis|
|US9149374||Apr 23, 2014||Oct 6, 2015||Idev Technologies, Inc.||Methods for manufacturing secured strand end devices|
|US9295551||May 12, 2008||Mar 29, 2016||Jenavalve Technology Gmbh||Methods of implanting an endoprosthesis|
|US9408729||Jan 20, 2015||Aug 9, 2016||Idev Technologies, Inc.||Secured strand end devices|
|US9408730||Jan 19, 2016||Aug 9, 2016||Idev Technologies, Inc.||Secured strand end devices|
|US9445896 *||Jul 2, 2009||Sep 20, 2016||Jenavalve Technology, Inc.||Methods for treating a heart valve insufficiency or stenosis|
|US9468435||Dec 23, 2009||Oct 18, 2016||Cook Medical Technologies Llc||Wound closure device|
|US20070027520 *||Jul 27, 2005||Feb 1, 2007||Sherburne Paul S||Stent removal from a body|
|US20080051867 *||Aug 28, 2006||Feb 28, 2008||Davila Luis A||Multiple in vivo implant delivery device|
|US20080255661 *||Jun 14, 2007||Oct 16, 2008||Helmut Straubinger||Medical device for treating a heart valve insufficiency or stenosis|
|US20100174362 *||Jul 2, 2009||Jul 8, 2010||Helmut Straubinger||Medical Device for Treating A Heart Valve Insufficiency or Stenosis|
|U.S. Classification||623/1.11, 606/108, 606/198|
|International Classification||A61F2/06, A61F2/84, A61B, A61B17/00, A61F11/00|
|Cooperative Classification||A61F2/966, A61F2002/9517, A61F2250/008, A61F2/95|
|May 11, 2009||AS||Assignment|
Owner name: MERIT MEDICAL SYSTEMS, INC., UTAH
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALVEOLUS, INC.;REEL/FRAME:022665/0280
Effective date: 20090310
|Jan 25, 2013||AS||Assignment|
Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINIS
Effective date: 20121219
Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:029698/0033
|Mar 18, 2013||FPAY||Fee payment|
Year of fee payment: 4